. Author manuscript; available in PMC: 2021 Feb 14.

Published in final edited form as: Invest New Drugs. 2015 Aug 16;33(5):1093–1099. doi: 10.1007/s10637-015-0277-8

Table 3.

Biomarker levels

	Baseline			Change (last cycle – first Cycle)			P Value
	Mean	Median	SD	Mean	Median	SD	P Value
IGF-1, ng/mL	114.7	96.5	55	−67.3	−55	35	0.0053
IGFBP-1, ng/mL	14.4	4.5	28	16	5.3	28.9	0.2336
IGFBP-3, ng/mL	2835.4	2776	847.1	−903.3	−687.5	780.6	0.0365

SD standard deviation